Related Experiment Video
Updated: Jun 4, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
[Acute dyspnea in malignant melanoma]
1Klinik für HNO-Krankheiten und plastische Operationen, Ruppiner Kliniken GmbH, Fehrbelliner Straße 38, 16816, Neuruppin, Deutschland. a.franzen@ruppiner-kliniken.de
HNO
|March 2, 2011
Summary
Metastases to the larynx from cutaneous melanoma are rare but serious, often presenting years after initial treatment. This rare laryngeal metastasis indicates widespread cancer and has a fatal prognosis.
Area of Science:
- Oncology
- Otolaryngology
Background:
- Metastases to the larynx are uncommon, with laryngeal involvement representing a rare manifestation of disseminated cancer.
- Cutaneous melanoma is a significant primary malignancy with the potential for distant spread.
Observation:
- A case report details a 75-year-old patient with a supraglottic exophytic lesion causing shortness of breath.
- The lesion was histologically confirmed as a metastasis from a cutaneous melanoma diagnosed 2.5 years prior.
- A literature review identified approximately 30 published cases of laryngeal melanoma metastasis.
Findings:
- Primary cutaneous melanomas spread to the larynx typically present as supraglottic, exophytic, red-colored lesions.
- A significant time interval often exists between the primary cutaneous melanoma diagnosis and the development of laryngeal metastasis.
- Histological examination is essential for definitive diagnosis of laryngeal metastasis.
Implications:
- Laryngeal metastasis from cutaneous melanoma signifies advanced tumor dissemination.
- The prognosis for patients with laryngeal melanoma metastasis is universally fatal.
- Increased awareness and diagnostic vigilance for rare metastatic sites like the larynx are crucial in melanoma management.
Related Concept Videos
Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: